Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Breast Cancer - Metaplastic

This section has been reviewed and approved by the Cancer.Net Editorial Board, 8/2010
Latest Research

Research for metaplastic breast cancer is ongoing. The following advances may still be under investigation in clinical trials and may not be approved or available at this time. Always discuss all diagnostic and treatment options with your doctor.

  • Drugs that target the epidermal growth factor receptor (EGFR, a protein involved in the abnormal growth of cancer cells) and a receptor for c-kit (a protein that when mutated or changed may be involved in the development of cancer) are being tested in clinical trials.
  • Drugs that target the angiogenesis process are being tested in clinical trials.
  • New surgical methods that save tissue or prevent scarring are being tested in clinical trials. A skin-sparing mastectomy may result in less scarring than traditional surgery.
  • Improved radiation therapy, to lower the risk of side effects

Looking for More about Current Research?

If you would like additional information about the latest areas of research regarding metaplastic breast cancer cancer, explore these related items:

Or, choose “Next” (below, right) to continue reading this detailed section.

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: